1. Home
  2. TNGX vs ACEL Comparison

TNGX vs ACEL Comparison

Compare TNGX & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • ACEL
  • Stock Information
  • Founded
  • TNGX 2014
  • ACEL 2009
  • Country
  • TNGX United States
  • ACEL United States
  • Employees
  • TNGX 140
  • ACEL N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • ACEL Services-Misc. Amusement & Recreation
  • Sector
  • TNGX Health Care
  • ACEL Consumer Discretionary
  • Exchange
  • TNGX Nasdaq
  • ACEL Nasdaq
  • Market Cap
  • TNGX 747.9M
  • ACEL 951.1M
  • IPO Year
  • TNGX N/A
  • ACEL N/A
  • Fundamental
  • Price
  • TNGX $6.98
  • ACEL $11.50
  • Analyst Decision
  • TNGX Strong Buy
  • ACEL Strong Buy
  • Analyst Count
  • TNGX 8
  • ACEL 1
  • Target Price
  • TNGX $15.14
  • ACEL $16.00
  • AVG Volume (30 Days)
  • TNGX 1.3M
  • ACEL 169.8K
  • Earning Date
  • TNGX 11-06-2024
  • ACEL 11-05-2024
  • Dividend Yield
  • TNGX N/A
  • ACEL N/A
  • EPS Growth
  • TNGX N/A
  • ACEL N/A
  • EPS
  • TNGX N/A
  • ACEL 0.57
  • Revenue
  • TNGX $42,509,000.00
  • ACEL $1,195,795,000.00
  • Revenue This Year
  • TNGX $18.15
  • ACEL $5.60
  • Revenue Next Year
  • TNGX N/A
  • ACEL $3.64
  • P/E Ratio
  • TNGX N/A
  • ACEL $20.20
  • Revenue Growth
  • TNGX 26.16
  • ACEL 5.74
  • 52 Week Low
  • TNGX $5.15
  • ACEL $9.37
  • 52 Week High
  • TNGX $13.01
  • ACEL $12.61
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 33.20
  • ACEL 49.97
  • Support Level
  • TNGX $6.72
  • ACEL $11.30
  • Resistance Level
  • TNGX $7.78
  • ACEL $11.71
  • Average True Range (ATR)
  • TNGX 0.56
  • ACEL 0.21
  • MACD
  • TNGX -0.11
  • ACEL -0.06
  • Stochastic Oscillator
  • TNGX 8.48
  • ACEL 20.00

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About ACEL Accel Entertainment Inc.

Accel Entertainment Inc is a distributed gaming operator in the United States. It is engaged in the installation, maintenance, and operation of video gaming terminals. The company offers products to restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. It operates slot machines and amusement equipment. The company generates a majority of its revenue from net gaming. Net gaming revenue represents net cash received from gaming activities, which is the difference between gaming wins and losses. Net gaming revenue includes the amount earned by location partners and is recognized at the time of gaming play.

Share on Social Networks: